Combinatorial discovery of microtopographical landscapes that resist biofilm formation through quorum sensing mediated autolubrication.

Journal: Nature communications
Published Date:

Abstract

Bio-instructive materials that intrinsically inhibit biofilm formation have significant anti-biofouling potential in industrial and healthcare settings. Since bacterial surface attachment is sensitive to surface topography, we experimentally surveyed 2176 combinatorially generated shapes embossed into polymers using an unbiased screen. This identified microtopographies that, in vitro, reduce colonization by pathogens associated with medical device-related infections by up to 15-fold compared to a flat polymer surface. Machine learning provided design rules, based on generalisable descriptors, for predicting biofilm-resistant microtopographies. On tracking single bacterial cells we observed that the motile behaviour of Pseudomonas aeruginosa is markedly different on anti-attachment microtopographies compared with pro-attachment or flat surfaces. Inactivation of Rhl-dependent quorum sensing in P. aeruginosa through deletion of rhlI or rhlR restored biofilm formation on the anti-attachment topographies due to the loss of rhamnolipid biosurfactant production. Exogenous provision of N-butanoyl-homoserine lactone to the rhlI mutant inhibited biofilm formation, as did genetic complementation of the rhlI, rhlR or rhlA mutants. These data are consistent with confinement-induced anti-adhesive rhamnolipid biosurfactant 'autolubrication'. In a murine foreign body infection model, anti-attachment topographies are refractory to P. aeruginosa colonization. Our findings highlight the potential of simple topographical patterning of implanted medical devices for preventing biofilm associated infections.

Authors

  • Manuel Romero
    School of Life Sciences, University of Nottingham, Nottingham, United Kingdom.
  • Jeni Luckett
    School of Life Sciences, University of Nottingham, Nottingham, United Kingdom.
  • Jean-Frédéric Dubern
    School of Life Sciences, University of Nottingham, Nottingham, United Kingdom.
  • Grazziela P Figueredo
    School of Computer Science, University of Nottingham, Nottingham, United Kingdom.
  • Elizabeth Ison
    School of Life Sciences, University of Nottingham, Nottingham, United Kingdom.
  • Alessandro M Carabelli
    School of Pharmacy, University of Nottingham, Nottingham, United Kingdom.
  • David J Scurr
    School of Pharmacy, University of Nottingham, Nottingham, United Kingdom.
  • Andrew L Hook
    School of Pharmacy, University of Nottingham, Nottingham, United Kingdom.
  • Lisa Kammerling
    School of Life Sciences, University of Nottingham, Nottingham, United Kingdom.
  • Ana C da Silva
    School of Life Sciences, University of Nottingham, Nottingham, United Kingdom.
  • Xuan Xue
    School of Pharmacy, University of Nottingham, Nottingham, United Kingdom.
  • Chester Blackburn
    School of Pharmacy, University of Nottingham, Nottingham, United Kingdom.
  • Aurélie Carlier
    MERLN Institute for Technology-Inspired Regenerative Medicine, Maastricht University, Maastricht, The Netherlands.
  • Aliaksei Vasilevich
    Department of Biomedical Engineering, Eindhoven University of Technology, Eindhoven, The Netherlands.
  • Phani K Sudarsanam
    Department of Biomedical Engineering, Eindhoven University of Technology, Eindhoven, The Netherlands.
  • Steven Vermeulen
    MERLN Institute for Technology-Inspired Regenerative Medicine, Maastricht University, Maastricht, The Netherlands.
  • David A Winkler
    The Department of Biochemistry and Chemistry La Trobe Institute for Molecular Science La Trobe University Bundoora Victoria Australia.
  • Amir M Ghaemmaghami
    Division of Immunology, School of Life Sciences, Faculty of Medicine and Health Sciences, University of Nottingham, Nottingham, NG7 2RD, UK. Amir.Ghaemmaghami@nottingham.ac.uk.
  • Jan de Boer
    Department of Biomedical Engineering, Eindhoven University of Technology, Eindhoven, The Netherlands.
  • Morgan R Alexander
    Advanced Materials and Healthcare Technologies Division, School of Pharmacy, University of Nottingham, Nottingham, NG7 2RD, UK.
  • Paul Williams
    School of Life Sciences, University of Nottingham, Nottingham, United Kingdom. paul.williams@nottingham.ac.uk.